Page 27 - SFHN917pages40pfinal.qxp_SFHN 0608 Friday 5.0
P. 27

Innovative Clinical Trial Underway Which Studies New Technology

                         and Technique to Improve Total Knee Replacement Results


          As the principal investigator overseeing a clinical trial                   if the integration of intraoperative sensing data had the potential to decrease the
        studying a new technology and technique for Total Knee                        need for all component revision. In this review, approximately 88 percent of
        Replacement (TKR) surgery, I am delighted to share details on                 intended total component revisions were changed to partial revisions based on
        ground-breaking advancements which may potentially help                       the surgeons’ interpretation of the sensor feedback. This sparing of components
        an even greater number of patients who are not satisfied with                 saved an estimated $4,990 in healthcare provider implant costs, per case.
        the results from an earlier knee replacement.                                 Because only one component was changed and not two, patients benefited by
          Total Knee Replacement has been a well-established and                      requiring less operative dissection, less bone loss, less operative time and often
        successful procedure for over 50 years and has helped mil-                    a faster and easier recovery.
        lions of people worldwide. More than 750,000 TKRs are per-                      As the surgeon takes the knee through a range of motion (ROM), dynamic
        formed each year in the United States and recent studies indi-                load measurements are generated for the lateral and medial tibial compart-
        cate that number is expected to increase more than 650 per-                   ments. A reference location of the load in each compartment throughout the
        cent from 2005 through 2025.                                                  ROM can also be used to evaluate knee kinematics. Armed with this data, Dr.
          While the vast majority of patients are very pleased with  BY WILLIAM A. LEONE,  Leone will be able to determine if compartmental loading and knee kinematics
        their outcome, multiple studies have revealed that 20-30 per-  M.D., F .A.C.S.  are desirable or if further resection or soft-tissue releases are indicated.
        cent of individuals are not satisfied following TKR, when                      The most consistent and best results after TKR are in those patients whose
        measured with validated patient reported outcome measures                     knee movement after TKR most closely matches their natural knee movement
        (PROM). Component malposition, malrotation, and soft tissue imbalance can result  before TKR and when soft tissue loads medially and laterally are nearly equal and
        in pain, stiffness and instability and are common reasons for dissatisfaction after  physiologic. These patients are also most likely to report that their TKR feels natural
        TKR. These conditions are often difficult to recognize at the time of surgery and dif-  and comfortable.
        ficult to correct until now.                                               The data from the sensors may enable the surgeon to address such soft-tissue
          For the last several years, I have been utilizing a new FDA approved technology,  abnormalities that may otherwise be unknown during traditional total knee revision
        VERASENSETM by OrthoSensor Inc., which incorporates microelectronics and sen-  procedures. Furthermore, the economic implications from converting a total revision
        sors to measure real-time kinetics and intercompartmental loading during total knee  to a partial revision could have a profound effect on the patient and healthcare
        arthroplasty (TKA). A computer microchip and load sensors are incorporated into  provider, such as decreased rehabilitation regimes and opportunity for cost savings.
        trial tray inserts whose geometries match exactly the geometry of the final plastic  Eligible revision patients who agree to participate will be followed for a period of 12
        insert provided by the manufacturer. These sensor trials are placed in the tibial tray  months after the revision procedure. I have outlined the patient eligibility criteria
        both during the “trialing phase” and after the final components are implanted for  below.
        “final trialing.”
          Holy Cross Hospital is currently heading up a multicenter study using     For more information, a list of the study eligibility criteria, or to schedule an evaluation,
        VERASENSE to evaluate Revision TKR. This study attempts to draw relationships  contact The Leone Center for Orthopedic Care at Holy Cross Hospital at (954) 489-4575
        between the soft-tissue related complications contributing to early TKA revision and        or LeoneCenter@holy-cross.com or visit holycrossleonecenter.com.
        the loading and positional patterns observed using intraoperative tibial trial sensors.
          Over the last several years I have been using VERASENSE during revision TKR. A           Dr. William Leone is head of The Leone Center for Orthopedic Care.
        few colleagues and I looked at a series of revision cases retrospectively to determine



          MAKINGROUNDS…MAKINGROUNDS…MAKINGROUNDS…





         Interventional Cardiologist Joins                                       Ronald Young, II, M.D.,
         Tenet Florida Physician Services in                                     Distinguished Neurosurgeon,
         Fort Lauderdale                                                         Joins Brain and Spine Center
                                                                                 South Florida
          Tenet Florida Physician Services (TFPS) is pleased to
         announce Ricardo Vicuna, M.D., FACC, FASE, a board-cer-
         tified interventional cardiologist, has joined the TFPS mul-              Ronald L. Young, II, M.D., recently joined the Brain and
         tispecialty physician group with an office located in Fort              Spine Center South Florida team of board-certified neuro-
         Lauderdale.                                          Dr. Ricardo Vicuna  surgery specialists. He brings more than 20 years of expe-  Dr. Ronald L. Young, II
          Prior to joining TFPS, Dr. Vicuna worked in a Miami-                   rience in treating brain tumors, hydrocephalus, traumatic
         based private cardiology practice with colleague, Dr. David Perloff, a general and  brain injuries, cervical spine problems, spinal cord tumors, and other brain, neck
         invasive cardiologist. Dr. Vicuna is also clinical assistant professor in the Department  and spine conditions.
         of Internal Medicine, Division of Cardiology at Nova Southeastern University’s  Dr. Young was affiliated with Terre Haute Regional Hospital in Indiana before mov-
         College of Osteopathic Medicine.                                        ing to Palm Beach County. He was listed as one of the top neurosurgeons in the
          Dr. Vicuna completed an interventional cardiology and cardiology fellowship at  Indianapolis area for eight of the last 10 years, and was twice recognized as one of
         the University of Illinois Chicago Medical Center in Chicago, IL, and a cardiovascu-  the top innovators in medicine in the Indianapolis area.
         lar magnetic resonance/cardiac CT fellowship at William Beaumont Hospital in  He has spoken at national and international conferences, including medical edu-
         Royal Oak, MI. Dr. Vicuna completed an internal medicine residency at the  cational events at University of New South Wales in Australia and the World
         University of Illinois Chicago Medical Center. He graduated medical school from  Congress of Hydrocephalus in New Zealand.
         Cayetano Heredia University, Medical School in Lima, Peru.
                                                                                                E-mail Your Physician Appointments to
         Palm Beach Gardens Medical Center                                                     editorial@southfloridahospitalnews.com

         Names New Medical Director of

         Bariatric Program


          Palm Beach Gardens Medical Center appoints John Bacha,
         D.O., as its new medical director of the bariatric program.
          Dr. Bacha is a board certified general surgeon who special-
         izes in bariatric procedures.  Dr. Bacha received his bariatric
         and robotic training at Wayne State University and the  Dr.  John Bacha
         University of Miami. He then completed his residency
         through Michigan State University at Macomb-Oakland Hospital in Madison
         Heights, Michigan. He earned his medical degree from Lake Erie College of
         Osteopathic Medicine in Erie, Pennsylvania. He received his bachelor’s degree from
         Penn State University, graduating with honors in Biology.


        South Florida Hospital News                                                              southfloridahospitalnews.com                                                       September 2017                          27
   22   23   24   25   26   27   28   29   30   31   32